• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.PRMT5-RNF168-SMURF2 轴控制 H2AX 稳态。
Cell Rep. 2019 Sep 17;28(12):3199-3211.e5. doi: 10.1016/j.celrep.2019.08.031.
2
RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling.RNF168 泛素化 H2A/H2AX 上的 K13-15 以驱动 DNA 损伤信号转导。
Cell. 2012 Sep 14;150(6):1182-95. doi: 10.1016/j.cell.2012.08.005.
3
USP7 deubiquitinase promotes ubiquitin-dependent DNA damage signaling by stabilizing RNF168.USP7去泛素化酶通过稳定RNF168促进泛素依赖性DNA损伤信号传导。
Cell Cycle. 2015;14(9):1413-25. doi: 10.1080/15384101.2015.1007785.
4
An RNF168 fragment defective for focal accumulation at DNA damage is proficient for inhibition of homologous recombination in BRCA1 deficient cells.一个在DNA损伤处缺乏焦点聚集功能的RNF168片段在BRCA1缺陷细胞中对同源重组的抑制功能正常。
Nucleic Acids Res. 2014 Jul;42(12):7720-33. doi: 10.1093/nar/gku421. Epub 2014 May 14.
5
RNF126 Quenches RNF168 Function in the DNA Damage Response.RNF126 可使 DNA 损伤反应中的 RNF168 失活。
Genomics Proteomics Bioinformatics. 2018 Dec;16(6):428-438. doi: 10.1016/j.gpb.2018.07.004. Epub 2018 Dec 4.
6
The E3 ubiquitin ligase CHIP mediates ubiquitination and proteasomal degradation of PRMT5.E3泛素连接酶CHIP介导PRMT5的泛素化和蛋白酶体降解。
Biochim Biophys Acta. 2016 Feb;1863(2):335-46. doi: 10.1016/j.bbamcr.2015.12.001. Epub 2015 Dec 2.
7
RNF168, a new RING finger, MIU-containing protein that modifies chromatin by ubiquitination of histones H2A and H2AX.RNF168,一种新的含RING指结构域和MIU结构域的蛋白质,通过对组蛋白H2A和H2AX进行泛素化修饰来改变染色质。
BMC Mol Biol. 2009 Jun 5;10:55. doi: 10.1186/1471-2199-10-55.
8
Dub3 controls DNA damage signalling by direct deubiquitination of H2AX.Dub3通过对H2AX进行直接去泛素化来控制DNA损伤信号传导。
Mol Oncol. 2014 Jul;8(5):884-93. doi: 10.1016/j.molonc.2014.03.003. Epub 2014 Mar 18.
9
Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5.MTAP/CDKN2A 缺失型癌症中的蛋氨酸代谢紊乱导致对 PRMT5 的依赖性。
Science. 2016 Mar 11;351(6278):1208-13. doi: 10.1126/science.aad5944. Epub 2016 Feb 11.
10
RNF168-mediated H2A neddylation antagonizes ubiquitylation of H2A and regulates DNA damage repair.RNF168介导的组蛋白H2A的NEDD化修饰拮抗H2A的泛素化修饰并调控DNA损伤修复。
J Cell Sci. 2014 May 15;127(Pt 10):2238-48. doi: 10.1242/jcs.138891. Epub 2014 Mar 14.

引用本文的文献

1
Combined inhibition by PRMT5 and MAT2A demonstrates a strong synthetic lethality in MTAP homozygous-deficient glioma models.PRMT5和MAT2A的联合抑制在MTAP纯合缺陷型胶质瘤模型中显示出强大的合成致死性。
Cell Death Discov. 2025 May 31;11(1):261. doi: 10.1038/s41420-025-02545-2.
2
The expression of PRMT5 is associated with postoperative chemotherapeutic outcome in colon cancer.PRMT5的表达与结肠癌术后化疗结果相关。
BMC Cancer. 2025 Apr 23;25(1):760. doi: 10.1186/s12885-025-14161-5.
3
Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP-Deficient Glioma May Be Influenced by Surrounding Normal Cells.PRMT5/MTA抑制剂对缺乏MTAP的胶质瘤的抑制作用可能受周围正常细胞的影响。
Cancer Med. 2024 Dec;13(24):e70526. doi: 10.1002/cam4.70526.
4
Identification of PRMT5 as a therapeutic target in cholangiocarcinoma.鉴定PRMT5作为胆管癌的治疗靶点。
Gut. 2024 Dec 10;74(1):116-127. doi: 10.1136/gutjnl-2024-332998.
5
CPEB1 Controls NRF2 Proteostasis and Ferroptosis Susceptibility in Pancreatic Cancer.CPEB1 控制胰腺癌中的 NRF2 蛋白稳态和铁死亡易感性。
Int J Biol Sci. 2024 Jun 3;20(8):3156-3172. doi: 10.7150/ijbs.95962. eCollection 2024.
6
PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma.PRMT5作为MYC扩增型髓母细胞瘤的潜在治疗靶点。
Cancers (Basel). 2023 Dec 15;15(24):5855. doi: 10.3390/cancers15245855.
7
PRMT1 and PRMT5: on the road of homologous recombination and non-homologous end joining.蛋白质精氨酸甲基转移酶1和5:在同源重组和非同源末端连接的道路上
Genome Instab Dis. 2023 Aug;4(4):197-209. doi: 10.1007/s42764-022-00095-w. Epub 2022 Dec 7.
8
Inhibiting PRMT5 induces DNA damage and increases anti-proliferative activity of Niraparib, a PARP inhibitor, in models of breast and ovarian cancer.抑制 PRMT5 可诱导 DNA 损伤,并增加 PARP 抑制剂尼拉帕利在乳腺癌和卵巢癌模型中的抗增殖活性。
BMC Cancer. 2023 Aug 18;23(1):775. doi: 10.1186/s12885-023-11260-z.
9
Critical Roles of Protein Arginine Methylation in the Central Nervous System.蛋白质精氨酸甲基化在中枢神经系统中的关键作用。
Mol Neurobiol. 2023 Oct;60(10):6060-6091. doi: 10.1007/s12035-023-03465-x. Epub 2023 Jul 6.
10
Autophagy dictates sensitivity to PRMT5 inhibitor in breast cancer.自噬决定了乳腺癌对 PRMT5 抑制剂的敏感性。
Sci Rep. 2023 Jul 3;13(1):10752. doi: 10.1038/s41598-023-37706-9.

本文引用的文献

1
MTAP Loss Promotes Stemness in Glioblastoma and Confers Unique Susceptibility to Purine Starvation.MTAP 缺失促进胶质母细胞瘤中的干性并赋予对嘌呤饥饿的独特易感性。
Cancer Res. 2019 Jul 1;79(13):3383-3394. doi: 10.1158/0008-5472.CAN-18-1010. Epub 2019 Apr 30.
2
PRMT5 Regulates DNA Repair by Controlling the Alternative Splicing of Histone-Modifying Enzymes.PRMT5 通过调控组蛋白修饰酶的可变剪接调控 DNA 修复。
Cell Rep. 2018 Sep 4;24(10):2643-2657. doi: 10.1016/j.celrep.2018.08.002.
3
β-Sheet Augmentation Is a Conserved Mechanism of Priming HECT E3 Ligases for Ubiquitin Ligation.β-折叠片层增强是触发 HECT E3 连接酶泛素化连接的一种保守机制。
J Mol Biol. 2018 Sep 14;430(18 Pt B):3218-3233. doi: 10.1016/j.jmb.2018.06.044. Epub 2018 Jun 28.
4
SWISS-MODEL: homology modelling of protein structures and complexes.SWISS-MODEL:蛋白质结构和复合物的同源建模。
Nucleic Acids Res. 2018 Jul 2;46(W1):W296-W303. doi: 10.1093/nar/gky427.
5
5-Fluorouracil targets histone acetyltransferases p300/CBP in the treatment of colorectal cancer.5-氟尿嘧啶通过靶向组蛋白乙酰转移酶 p300/CBP 治疗结直肠癌。
Cancer Lett. 2017 Aug 1;400:183-193. doi: 10.1016/j.canlet.2017.04.033. Epub 2017 Apr 29.
6
Shaping proteostasis at the cellular, tissue, and organismal level.在细胞、组织和机体水平塑造蛋白质稳态。
J Cell Biol. 2017 May 1;216(5):1231-1241. doi: 10.1083/jcb.201612111. Epub 2017 Apr 11.
7
A PALB2-interacting domain in RNF168 couples homologous recombination to DNA break-induced chromatin ubiquitylation.RNF168中与PALB2相互作用的结构域将同源重组与DNA断裂诱导的染色质泛素化联系起来。
Elife. 2017 Feb 27;6:e20922. doi: 10.7554/eLife.20922.
8
PRMT5-Dependent Methylation of the TIP60 Coactivator RUVBL1 Is a Key Regulator of Homologous Recombination.依赖蛋白精氨酸甲基转移酶5(PRMT5)的TIP60共激活因子RUVBL1甲基化是同源重组的关键调节因子。
Mol Cell. 2017 Mar 2;65(5):900-916.e7. doi: 10.1016/j.molcel.2017.01.019. Epub 2017 Feb 23.
9
Proteasome inhibitors in cancer therapy.蛋白酶体抑制剂在癌症治疗中的应用。
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433. doi: 10.1038/nrclinonc.2016.206. Epub 2017 Jan 24.
10
GlioVis data portal for visualization and analysis of brain tumor expression datasets.用于脑肿瘤表达数据集可视化与分析的GlioVis数据门户。
Neuro Oncol. 2017 Jan;19(1):139-141. doi: 10.1093/neuonc/now247. Epub 2016 Nov 9.

PRMT5-RNF168-SMURF2 轴控制 H2AX 稳态。

A PRMT5-RNF168-SMURF2 Axis Controls H2AX Proteostasis.

机构信息

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA; Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA; Gastrointestinal Cancer Center, Peking University Cancer Hospital, Beijing 100142, China.

The Preston Robert Tisch Brain Tumor Center, Duke University Medical Center, Durham, NC 27710, USA; Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA.

出版信息

Cell Rep. 2019 Sep 17;28(12):3199-3211.e5. doi: 10.1016/j.celrep.2019.08.031.

DOI:10.1016/j.celrep.2019.08.031
PMID:31533041
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7204040/
Abstract

H2AX safeguards genomic stability in a dose-dependent manner; however, mechanisms governing its proteostasis are poorly understood. Here, we identify a PRMT5-RNF168-SMURF2 cascade that regulates H2AX proteostasis. We show that PRMT5 sustains the expression of RNF168, an E3 ubiquitin ligase essential for DNA damage response (DDR). Suppression of PRMT5 occurs in methylthioadenosine phosphorylase (MTAP)-deficient glioblastoma cells and attenuates the expression of RNF168, leading to destabilization of H2AX by E3 ubiquitin ligase SMURF2. RNF168 and SMURF2 serve as a stabilizer and destabilizer of H2AX, respectively, via their dynamic interactions with H2AX. In supporting an important role of this signaling cascade in regulating H2AX, MTAP-deficient glioblastoma cells display higher levels of DNA damage spontaneously or in response to genotoxic agents. These findings reveal a regulatory mechanism of H2AX proteostasis and define a signaling cascade that is essential to DDR and that is disrupted by the loss of a metabolic enzyme in tumor cells.

摘要

H2AX 以剂量依赖的方式保护基因组稳定性;然而,其蛋白质稳定的机制仍知之甚少。在这里,我们发现了一个 PRMT5-RNF168-SMURF2 级联反应,它调节 H2AX 的蛋白质稳定。我们表明,PRMT5 维持 RNF168 的表达,RNF168 是 DNA 损伤反应(DDR)所必需的 E3 泛素连接酶。甲基硫腺苷磷酸酶(MTAP)缺陷型脑胶质瘤细胞中发生 PRMT5 抑制,导致 RNF168 表达减弱,从而导致 E3 泛素连接酶 SMURF2 使 H2AX 不稳定。RNF168 和 SMURF2 通过与 H2AX 的动态相互作用,分别作为 H2AX 的稳定剂和失稳剂。支持这种信号级联在调节 H2AX 中起重要作用,MTAP 缺陷型脑胶质瘤细胞在自发或对遗传毒性药物反应时显示出更高水平的 DNA 损伤。这些发现揭示了 H2AX 蛋白质稳定的调节机制,并定义了一个信号级联,该级联对于 DDR 是必不可少的,并且在肿瘤细胞中代谢酶的缺失会破坏该信号级联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/efd4555e8edb/nihms-1571088-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/bd8807de3e04/nihms-1571088-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/398d1caf3a2d/nihms-1571088-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/337bd5123b32/nihms-1571088-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/06d85408d9bb/nihms-1571088-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/2e79306fa2a3/nihms-1571088-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/54caee987e60/nihms-1571088-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/efd4555e8edb/nihms-1571088-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/bd8807de3e04/nihms-1571088-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/398d1caf3a2d/nihms-1571088-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/337bd5123b32/nihms-1571088-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/06d85408d9bb/nihms-1571088-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/2e79306fa2a3/nihms-1571088-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/54caee987e60/nihms-1571088-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7f9/7204040/efd4555e8edb/nihms-1571088-f0008.jpg